Press
SATT Nord and Lille University Hospital have signed an exclusive license agreement with Hemerion Therapeutics for the exploitation of a new anti-cancer technology.
Read more
Success stories, testimonials from our investors, and startup news.
Don't miss out on the latest news from Satt Nord ç!
Read more
Read more
Read more
Read more
Read more
Read more